Partial deletion of the long arm of chromosome 3 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:262019
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Partial deletion of the long arm of chromosome 3 syndrome (also known as 3q partial monosomy or partial monosomy 3q) is a rare chromosomal disorder caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 3. Because the deleted region can vary in size and location among affected individuals, the clinical presentation is highly variable. Common features may include intellectual disability, developmental delay, growth retardation, and a range of dysmorphic facial features such as a broad nasal bridge, micrognathia, low-set ears, and hypertelorism. Depending on the specific segment deleted, additional findings can involve congenital heart defects, skeletal anomalies, genitourinary malformations, and central nervous system abnormalities. The severity of the condition largely depends on the size and precise location of the deletion along chromosome 3q, as well as the specific genes encompassed within the deleted region. Some individuals may have relatively mild manifestations, while others can be more severely affected with multiple organ system involvement. Diagnosis is typically established through chromosomal analysis, including karyotyping and chromosomal microarray analysis (CMA), which can precisely define the breakpoints and extent of the deletion. There is no cure for this condition, and management is supportive and symptom-based. Treatment may include early intervention programs, speech and occupational therapy, special education services, cardiac surgery for congenital heart defects if present, and regular monitoring by a multidisciplinary team including geneticists, cardiologists, neurologists, and other specialists as needed. Genetic counseling is recommended for affected families to discuss recurrence risk and reproductive options.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Partial deletion of the long arm of chromosome 3 syndrome.

View clinical trials →

No actively recruiting trials found for Partial deletion of the long arm of chromosome 3 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial deletion of the long arm of chromosome 3 syndrome community →

No specialists are currently listed for Partial deletion of the long arm of chromosome 3 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Partial deletion of the long arm of chromosome 3 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial deletion of the long arm of chromosome 3 syndromeForum →

No community posts yet. Be the first to share your experience with Partial deletion of the long arm of chromosome 3 syndrome.

Start the conversation →

Latest news about Partial deletion of the long arm of chromosome 3 syndrome

No recent news articles for Partial deletion of the long arm of chromosome 3 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial deletion of the long arm of chromosome 3 syndrome

What is Partial deletion of the long arm of chromosome 3 syndrome?

Partial deletion of the long arm of chromosome 3 syndrome (also known as 3q partial monosomy or partial monosomy 3q) is a rare chromosomal disorder caused by the loss of a segment of genetic material from the long arm (q arm) of chromosome 3. Because the deleted region can vary in size and location among affected individuals, the clinical presentation is highly variable. Common features may include intellectual disability, developmental delay, growth retardation, and a range of dysmorphic facial features such as a broad nasal bridge, micrognathia, low-set ears, and hypertelorism. Depending on

At what age does Partial deletion of the long arm of chromosome 3 syndrome typically begin?

Typical onset of Partial deletion of the long arm of chromosome 3 syndrome is neonatal. Age of onset can vary across affected individuals.